{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/macular-degeneration-age-related/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"a82ab674-261f-5a3d-8d12-5c13643cd924","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 31c24e28-fc18-412e-996a-960eb7bc69f3 --><h2>Update</h2><!-- end field 31c24e28-fc18-412e-996a-960eb7bc69f3 -->","summary":null,"htmlStringContent":"<!-- begin item 7f08d0f4-8cdd-4128-b34b-c5f38670b152 --><!-- end item 7f08d0f4-8cdd-4128-b34b-c5f38670b152 -->","topic":{"id":"bb3e11cb-517f-5331-9de9-039d796fed2d","topicId":"819a45d3-fd1c-42c7-8420-27d4daf53cc2","topicName":"Macular degeneration - age-related","slug":"macular-degeneration-age-related","lastRevised":"Last revised in October 2020","chapters":[{"id":"8dda5709-9896-57f9-9907-7fb9c46fe863","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bb451071-7381-59cb-aa21-2b2bccafe2d2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"5006d91f-871e-5987-a351-38613676d868","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b46dda65-9a23-5d6c-9afe-03e05a87cc3c","slug":"changes","fullItemName":"Changes"},{"id":"a82ab674-261f-5a3d-8d12-5c13643cd924","slug":"update","fullItemName":"Update"}]},{"id":"e40fe343-86d1-5303-af86-c3b22d664113","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"807a5294-312b-51b7-8a2b-2b7d9c18a2a2","slug":"goals","fullItemName":"Goals"},{"id":"875cd1b7-ea38-5e4d-b1ac-1c4d4e110927","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1c4bcbde-43f9-57c5-87d2-37e2a7bfc7b3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"73e19abc-9ba2-505a-aae8-23b40e76c49f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cb9a7aab-681a-5b78-aca6-dcb97a9ae535","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"25a06a16-e897-5cb6-bdf2-99705c2c3f77","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7cb3e392-3b5c-558a-988c-646bacf307bb","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"69a4bcc6-b18d-52c2-b7f8-b74b4bebf32c","slug":"definition","fullItemName":"Definition"},{"id":"e34a411a-f7c0-5084-965b-49ac89736d30","slug":"classification","fullItemName":"Classification"},{"id":"d537f969-c989-57cd-824a-d0718c657988","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4098eb73-c982-50a6-830c-61d7dc25c997","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"c49a0066-054e-5666-9b2d-7bad39b079cc","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1313d171-0d54-5814-baef-2c79e54a147e","slug":"complications","fullItemName":"Complications"}]},{"id":"5daaa827-5772-5a33-8675-cf20b916db2e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7fd2b2d6-9e86-5014-bc61-f30ce19d5712","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"fa4cdf98-731f-5fab-b1b9-802d0ad26a9e","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"491fb145-6067-5e5d-b364-2a3d874dcbde","fullItemName":"Management","slug":"management","subChapters":[{"id":"623a85d0-3eef-5b46-a5a6-0c14facafc46","slug":"suspected-amd","fullItemName":"Scenario: Suspected AMD"},{"id":"1d91de12-c8ef-5335-9359-81816456fb81","slug":"confirmed-amd","fullItemName":"Scenario: Confirmed AMD"}]},{"id":"0c6673ad-62d1-59a7-93a7-dc791491644d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"81330a87-dcef-52cd-9707-efa0e22c0435","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"565ac27d-4e4d-5f6c-ba0a-bef0793f4f68","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"97a694f8-29e3-5e9b-9e46-68e52e2499d0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"adea819b-f313-5842-8936-3b1d2feee7ad","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e49d7e10-0bcd-5d89-b7f3-64d4ff858f1c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8059070a-a973-530d-8d9b-0e4cb14d5b65","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4ea345d9-fe7e-558f-b710-2bb252185ef8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5006d91f-871e-5987-a351-38613676d868","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"b918652f-7515-55a5-9c3a-6dea8a4ff14c","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 965bc0e4-df32-4b59-81b1-41368ffb96a6 --><h3>New evidence</h3><!-- end field 965bc0e4-df32-4b59-81b1-41368ffb96a6 -->","summary":null,"htmlStringContent":"<!-- begin item a242658c-abc8-468c-a2e2-7afc179ce05a --><!-- begin field 6eda3687-7bef-4e97-a46b-48255be2253c --><h3>Evidence-based guidelines</h3><!-- end field 6eda3687-7bef-4e97-a46b-48255be2253c --><!-- begin field ffa7907e-72e1-47a1-8ea6-35abef561d37 --><ul><li>NICE (2021) <em>Brolucizumab for treating wet age-related macular degeneration.</em> National Institute for Health and Care Excellence. <a href=\"https://www.nice.org.uk/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"777ab682-5228-408e-9d51-acc600ed0e52\">www.nice.org.uk</a> [<a href=\"https://www.nice.org.uk/guidance/ta672\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"611f1482-2857-44cc-93cc-acc600ed0e53\">Free Full-text</a>]</li></ul><!-- end field ffa7907e-72e1-47a1-8ea6-35abef561d37 --><!-- begin field e264fb46-c0a6-4b30-8687-4a93eb4b745f --><h3>HTAs (Health Technology Assessments)</h3><!-- end field e264fb46-c0a6-4b30-8687-4a93eb4b745f --><!-- begin field 29da1338-27de-4b64-867c-ae026e4ca788 --><p>No new HTAs since 1 October 2020.</p><!-- end field 29da1338-27de-4b64-867c-ae026e4ca788 --><!-- begin field 340c381b-7840-402b-adc5-04094c978612 --><h3>Economic Appraisals</h3><!-- end field 340c381b-7840-402b-adc5-04094c978612 --><!-- begin field c911921c-81d2-43b7-b5cd-a1f854a88752 --><p>No new economic appraisals relevant to England since 1 October 2020.</p><!-- end field c911921c-81d2-43b7-b5cd-a1f854a88752 --><!-- begin field e95cd31c-6573-4f9e-814a-b9644cb7fd9e --><h3>Systematic reviews and meta-analyses</h3><!-- end field e95cd31c-6573-4f9e-814a-b9644cb7fd9e --><!-- begin field 8f328a84-89c0-4caf-a736-85ac5c6a79b3 --><p>No new systematic reviews or meta-analyses since 1 October 2020.</p><!-- end field 8f328a84-89c0-4caf-a736-85ac5c6a79b3 --><!-- begin field 03fc8673-b08a-4d27-8ef8-a36fe82f0879 --><h3>Primary evidence</h3><!-- end field 03fc8673-b08a-4d27-8ef8-a36fe82f0879 --><!-- begin field 3a01e358-22b5-446a-ac62-65a2d40f68b5 --><p>No new randomized controlled trials published in the major journals since 1 October 2020.</p><!-- end field 3a01e358-22b5-446a-ac62-65a2d40f68b5 --><!-- end item a242658c-abc8-468c-a2e2-7afc179ce05a -->","subChapters":[]},{"id":"53469e1b-3567-5d42-a4f8-6eef6a142a2a","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field fe54d01d-3e97-457d-93cb-b771148b220f --><h3>New policies</h3><!-- end field fe54d01d-3e97-457d-93cb-b771148b220f -->","summary":null,"htmlStringContent":"<!-- begin item f622f7c0-5c46-438f-bbe6-5e91b5e0758e --><!-- begin field ba187bf6-82de-4fc9-af21-480213fdf4fe --><p>No new national policies or guidelines since 1 October 2020.</p><!-- end field ba187bf6-82de-4fc9-af21-480213fdf4fe --><!-- end item f622f7c0-5c46-438f-bbe6-5e91b5e0758e -->","subChapters":[]},{"id":"e1e6bbdb-e34e-5d8a-a2b7-f918d2f7657e","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 4461645f-1086-4b62-b84b-4435aeddf999 --><h3>New safety alerts</h3><!-- end field 4461645f-1086-4b62-b84b-4435aeddf999 -->","summary":null,"htmlStringContent":"<!-- begin item 8c313fd8-361c-4703-89e8-84fbb3cd9cbc --><!-- begin field 1bd19acd-1bec-4cfd-a1b0-866ab39faca1 --><p>No new safety alerts since 1 October 2020.</p><!-- end field 1bd19acd-1bec-4cfd-a1b0-866ab39faca1 --><!-- end item 8c313fd8-361c-4703-89e8-84fbb3cd9cbc -->","subChapters":[]},{"id":"cf252f40-d24a-597b-9c83-010305c007b3","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field e95c304e-ac4f-422f-9675-cdce52145acf --><h3>Changes in product availability</h3><!-- end field e95c304e-ac4f-422f-9675-cdce52145acf -->","summary":null,"htmlStringContent":"<!-- begin item bc7667d0-cab3-46c9-b606-6c2c7390642b --><!-- begin field f1c83afe-851f-4cd9-b587-335baf2e14cb --><p>No changes in product availability since 1 October 2020.</p><!-- end field f1c83afe-851f-4cd9-b587-335baf2e14cb --><!-- end item bc7667d0-cab3-46c9-b606-6c2c7390642b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}